3 Bargain Stocks for Budget-Conscious Investors
With financial constraints tightening for most Americans, investing wisely has become a necessity rather than a luxury. Households are grappling with stagnant wages against rising living costs, leaving little room for market speculation. The average U.S. family holds just $8,000 in liquid savings—barely enough to cover three months of essentials.
Pfizer emerges as a defensive play amid this economic squeeze. Once buoyed by pandemic-driven vaccine sales, the pharmaceutical giant now trades at a fraction of its 2022 peak revenue of $100 billion. Analysts project just $63 billion in sales this year, creating potential value for risk-averse investors.